R. Senior et al., Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction, AM HEART J, 137(4), 1999, pp. 646-652
Citations number
35
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Objective The aim of the study was to assess the effects of carvedilol, a v
asodilating nonselective P-blocker, on the indexes of left ventricular remo
deling after acute myocardial infarction in those with left ventricular dys
function.
Methods and Results Forty-nine patients with predischarge left ventricular
election fraction <45% after acute myocardial infarction were evaluated in
a double-blind, randomized, placebo-controlled, parallel group study (selec
ted from the database of the Carvedilol Heart Attack Pilot Study: CHAPS). P
atients received medication after thrombolysis and continued to do so for 6
months. Two-dimensional echocardiography was performed before discharge (7
to 10 days after admission) and at 3 months after acute myocardial infarct
ion. Analysis of variance showed that wall thickness opposite the site of i
nfarction decreased from (mean +/- SD) 12.3 +/- 2.1 mm to 11.0 +/- 2.4 mm w
ith carvedilol compared with 11.6 +/- 1.9 mm to 12.2 +/- 1.9 mm with placeb
o (P = .01). left ventricular mass changed from 235 +/- 74 g to 217 +/- 64
g with carvedilol compared with 227 +/- 80 g to 252 +/- 85 g with placebo (
P = .02). Carvedilol prevented alteration of sphericity index (ratio of lon
g and short axis of left ventricle) that changed from 1.65 +/- 0.29 to 1.66
+/- 20 with carvedilol compared with 1.58 +/- 0.33 to 1.39 +/- 0.19 with p
lacebo (P = .02); alteration was also prevented of wail thickening abnormal
ity at infarct site, which changed from 9.2 +/- 3.1 cm(2) to 9.1 +/- 3.5 cm
(2) with carvedilol compared with 10.3 +/- 3.3 cm(2) to 13.5 +/- 4.6 cm(2)
with placebo (P = .002).
Conclusion Carvedilol administered early after acute myocardial infarction
results in attenuation of left ventricular remodeling in patients with pers
istent left ventricular dysfunction before discharge.